Literature DB >> 22253235

What rhinologists and allergists should know about the medico-legal implications of corticosteroid use: a review of the literature.

David M Poetker1, Timothy L Smith.   

Abstract

BACKGROUND: Corticosteroids are a mainstay of treatment in the management of sinonasal inflammatory disease. Despite their common use, many practitioners are not well versed in their potential complications or the medico-legal ramifications of their use. The objectives of this review were to outline the existing data of the medico-legal implications of oral steroids.
METHODS: An OVID database search of the terms "corticosteroids OR adrenal cortex hormones" AND "medico-legal OR malpractice OR jurisprudence OR expert testimony OR informed consent" was performed. This search was then narrowed to English language articles and the titles and abstracts were searched for relevance.
RESULTS: The OVID search identified 178 articles. This search was then narrowed, resulting in 9 articles that were relevant and included in the current review. Five articles involved database reviews of litigation associated with medications. Steroids were found to be a common medication associated with litigation and the cost of the litigation involving steroid use can be very high. Common themes associated with the litigation include poor communication and lack of informed consent regarding steroid use. Several additional articles addressed single cases and many addressed lawsuit prevention.
CONCLUSION: Lawsuits associated with steroids are disproportionately costly and most of the allegations stem from a lack of informed consent over the use of steroids. Open dialogue with patients is the key to informed consent. Ideally, clinicians should discuss the rationale for steroid use, and the risks, expected benefits, and alternatives of the steroid therapy. Document this discussion and consider providing educational material for the patient to read and review.
Copyright © 2012 American Rhinologic Society-American Academy of Otolaryngic Allergy, LLC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253235     DOI: 10.1002/alr.21016

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  7 in total

Review 1.  Management of patients with risk factors.

Authors:  Frank Waldfahrer
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

Review 2.  Glucocorticoid-induced osteoporosis and osteonecrosis.

Authors:  Robert S Weinstein
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-23       Impact factor: 4.741

Review 3.  Danger points, complications and medico-legal aspects in endoscopic sinus surgery.

Authors:  W Hosemann; C Draf
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

Review 4.  Oral steroid therapy in chronic rhinosinusitis with and without nasal polyposis.

Authors:  Brittany E Howard; Devyani Lal
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

Review 5.  A review of the revisions and complications management procedure in sinus surgery.

Authors:  Sara Khademi; Aida Kazemi; Reza Divanbeigi; Mohamadreza Afzalzadeh
Journal:  J Family Med Prim Care       Date:  2022-03-10

Review 6.  Fulminant Amebic Colitis after Corticosteroid Therapy: A Systematic Review.

Authors:  Debbie-Ann Shirley; Shannon Moonah
Journal:  PLoS Negl Trop Dis       Date:  2016-07-28

7.  Alleviation of Surgery-Induced Osteitis in Sinonasal Cavity by Dexamethasone-Loaded Poly(lactic-co-glycolic acid) (PLGA) Microparticles with Strong Calcium-Binding Affinity.

Authors:  Seung-No Hong; Minjae Kim; Jin-A Park; Minji Kang; Hyunkyung Cha; Sohyun Park; Joon Kon Kim; Jinyoung Pac; Yuju Seo; Sungwhan Kim; Minju Kim; Dae Woo Kim; Yan Lee
Journal:  Pharmaceutics       Date:  2022-02-28       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.